P&G Hygiene Q2 profit falls 6.7% to ₹196 crore on commodity, forex headwinds
Synopsis
P&G Hygiene posted a 6.7% profit drop in Q2 FY27 — not because demand collapsed, but because commodity and forex pressures delivered a double-digit earnings hit that even a strong productivity drive could only partially offset. With revenue flat and expenses rising, the maker of Whisper and Vicks is betting on brand investments to protect market share while margins recover.
Key Takeaways
PGHH reported a 6.7% YoY decline in Q2 FY27 net profit to ₹195.84 crore , down from ₹209.86 crore a year earlier.
Revenue from operations slipped marginally to ₹1,145 crore from ₹1,150.17 crore in Q2 FY26.
Total expenses rose 2.47% YoY to ₹900 crore , driven by higher raw material, energy, and forex costs.
Commodity cost fluctuations caused a double-digit adverse effect on earnings; a productivity programme offset a large part of the impact.
First-half FY27 total revenue declined a marginal 2% to ₹2,063 crore .
Shares closed flat at ₹7,200 on the BSE on Thursday.
Procter & Gamble Hygiene and Health Care Limited (PGHH), the maker of Whisper and Vicks, on Thursday, 12 November 2026 reported a 6.7% year-on-year decline in net profit for the quarter ended September FY27, weighed down by elevated raw material costs, higher energy expenses, and adverse currency movements. The company posted a profit after tax (PAT) of ₹195.84 crore, compared with ₹209.86 crore in the same quarter last year, according to a regulatory filing.
Revenue Holds Flat, Expenses Climb
Revenue from operations slipped marginally to ₹1,145 crore in the September quarter from ₹1,150.17 crore a year earlier, reflecting broadly flat demand conditions in the FMCG segment. Total expenses, however, rose 2.47% year-on-year to ₹900 crore, squeezing the company's margins further.
For the first half of FY27, PGHH recorded a marginal 2% decline in total revenue to ₹2,063 crore, compared with the year-ago period — suggesting the pressure is not confined to a single quarter.
Commodity and Forex Costs Dent Earnings
PGHH disclosed that commodity cost fluctuations delivered a double-digit adverse effect on its earnings during the quarter. Unfavourable foreign exchange rates compounded the challenge alongside higher raw material and energy bills. This comes amid a broader trend of input-cost volatility affecting fast-moving consumer goods companies across India, particularly those with significant import exposure.
Notably, the company said a substantial portion of the impact was cushioned through a strong productivity programme, which helped arrest a steeper earnings decline. Without these efficiencies, the profit contraction would likely have been sharper.
Brand Investments and Innovation Step Up
Despite the margin pressure, PGHH increased investments in innovation and advertising and promotional activities during the quarter compared with the preceding quarter. The move reflects a deliberate long-term strategy: protect market share in competitive categories like feminine care and healthcare even when near-term profitability is under strain. The company said it remains focused on productivity initiatives and brand investments to support long-term value creation.
Market Reaction and Outlook
Shares of PGHH ended flat at ₹7,200 per share on the Bombay Stock Exchange (BSE) on Thursday, suggesting investors had largely priced in the earnings softness. With commodity cycles inherently unpredictable, the trajectory of raw material prices and the rupee will be critical determinants of whether the company can recover margins in the second half of FY27.
Point of View
Rising input costs, and a currency that refused to cooperate. The double-digit commodity headwind is the real story, and the fact that management only partially mitigated it through productivity gains signals that pricing power remains constrained in feminine care and healthcare segments. Crucially, the company's decision to increase ad spend even as profits fell is a bet that brand equity now will buy volume later — a strategy that worked for peers in past cycles, but demands that commodity costs ease in H2 FY27. If they do not, the market's flat reaction on Thursday may prove premature optimism.
NationPress
12 Nov 2026
Frequently Asked Questions
What was P&G Hygiene's net profit in Q2 FY27?
Procter & Gamble Hygiene and Health Care reported a net profit (PAT) of ₹195.84 crore in Q2 FY27, a 6.7% decline compared with ₹209.86 crore in the same quarter of FY26. The fall was driven by higher commodity, energy, and forex costs.
Why did PGHH's profit fall in the September 2026 quarter?
The company cited commodity cost fluctuations that caused a double-digit adverse impact on earnings, compounded by higher energy expenses and unfavourable foreign exchange rates. A productivity programme offset a significant portion of the impact, limiting the decline to 6.7%.
How did P&G Hygiene's revenue perform in Q2 FY27?
Revenue from operations was broadly flat, slipping marginally to ₹1,145 crore from ₹1,150.17 crore in Q2 FY26. For the first half of FY27, total revenue declined a marginal 2% to ₹2,063 crore.
Which brands does Procter & Gamble Hygiene and Health Care sell in India?
PGHH operates in the feminine care and healthcare segments through brands such as Whisper and Vicks. These are among the leading consumer brands in their respective categories in India.
How did PGHH shares react to the Q2 results?
Shares of PGHH ended flat at ₹7,200 per share on the BSE on Thursday, 12 November 2026, suggesting the market had broadly anticipated the earnings softness.
